Market Views

Alios BioPharma to be acquired by Johnson & Johnson for $1.75 Billion

Johnson & Johnson said that it is going to purchase Alios BioPharma which is a private biotechnology company for $1.75 billion in cash. Alios BioPharma is developing a treatment for respiratory syncytial virus, which is known as RSV. Presently, the drug is in phase 2 studies. The head of research and development at Janssen Pharmaceutical […]

Subscribe to Consumer Goods

Consumer Goods

Subscribe to Energy & Power

Energy & Power

Subscribe to Life Sciences

Life Sciences

Subscribe to Materials & Chemicals

Materials & Chemicals

Subscribe to Public Sector

Public Sector